3 June 2021

Optimizing clinical trial design can have a huge influence on oncology studies that are dependent on imaging for evaluations. Depending on the study design, several alternatives can be considered for improving imaging results that support these endpoints: different assessment paradigms, incorporation of clinical data in addition to radiographic reads, etc… During this presentation, we review the relevance of each option for different study designs. Here are some insights that we discuss in our presentation:

  • Oncology study Endpoints include several assessments that are dependent on imaging criteria
  • When to use Ongoing Reads, Oncologist Reads and Global Reads
  • How to determine impact of read frequency including time sensitive reads during a study
  • Monitoring advantages for unique study designs and reader quality